Animal models for retinoid receptor research: Implications for epidermal homeostasis, skin barrier function, wound healing, and atopic dermatitis

Retinoids and Carotenoids in Dermatology

Volumn , Issue , 2007, Pages 27-54

  Ghyselinck, Norbert B ^a   Chambon, Pierre ^a  

^a Campus Universitaire de Strasbourg ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60549115886     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (150)

1. Cohen-Tannoudji M, Babinet C. Beyond “knock-out” mice: new perspectives for the programmed modification of the mammalian genome. Mol Hum Reprod 1998; 4(10): 929-938.
2. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 1995; 83(6): 859-869.
3. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10(9): 940-954.
4. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 2005; 19(6): 1418-1428.
5. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 2006; 46: 451-480.
6. Letterio JJ, Geiser AG, Kulkarni AB, et al. Maternal rescue of transforming growth factor-beta 1 null mice. Science 1994; 264(5167): 1936-1938.
7. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 1995; 92(26): 12215-12219.
8. Blagosklonny MV. Molecular theory of cancer. Cancer Biol Ther 2005; 4(6): 621-627.
9. Sauer B, Henderson N. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 1989; 17(1): 147-161.
10. Gu H, Marth J, Orban PC, et al. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994; 265(5168): 103-106.
11. Tsien JZ, Chen DF, Gerber D, et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996; 87(7): 1317-1326.
12. Akagi K, Sandig V, Vooijs M, et al. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 1997; 25(9): 1766-1773.
13. Barlow C, Schroeder M, Lekstrom-Himes J, et al. Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments. Nucleic Acids Res 1997; 25(12): 2543-2545.
14. Kuhn R, Schwenk F, Aguet M, et al. Inducible gene targeting in mice. Science 1995; 269(5229): 1427-1429.
15. Marth JD. Recent advances in gene mutagenesis by site-directed recombination. J Clin Invest 1996; 97(9): 1999-2002.
16. Rajewsky K, Gu H, Kuhn R, et al. Conditional gene targeting. J Clin Invest 1996; 98(3): 600-603.
17. Lobe C, Nagy A. Conditional genome alteration in mice. Bio Essays 1998; 20(3): 200-208.
18. Metzger D, Clifford J, Chiba H, et al. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U.S.A 1995; 92(15): 6991-6995.
19. Logie C, Stewart AF. Ligand-regulated site-specific recombination. Proc Natl Acad Sci U.S.A 1995; 92(13): 5940-5944.
20. Feil R, Brocard J, Mascrez B, et al. Ligand-activated site-specific recombination in mice. Proc. Natl Acad Sci U.S.A 1996; 93(20): 10887-10890.
21. Feil R, Wagner D, Metzger D, et al. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 1997; 237(3): 752-757.
22. Indra AK, Warot X, Brocard J, et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999; 27(22): 4324-4327.
23. Metzger D, Chambon P. Site- and time-specific gene targeting in the mouse. Methods 2001; 24(1): 71-80.
24. Metzger D, Indra AK, Li M, et al. Targeted conditional somatic mutagenesis in the mouse: temporally-controlled knock out of retinoid receptors in epidermal keratinocytes. Methods Enzymol 2003; 364: 379-408.
25. Fuchs E, Keith R Porter Lecture, 1996. Of mice and men: genetic disorders of the cytoskeleton. Mol Biol Cell 1997; 8(2): 189-203.
26. Hardy MH. The secret life of the hair follicle. Trends Genet 1992; 8(2): 55-61.
27. Paus R, Cotsarelis G. The biology of hair follicles. New Eng J Med 1999; 341(7): 491-497.
28. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001; 81(1): 449-494.
29. Muller-Rover S, Handjiski B, vand der Veen C, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001; 117(1): 3-15.
30. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10(9): 1002-1013.
31. Roos TC, Jugert FK, Merk HF, et al. Retinoid metabolism in the skin. Pharmacol Rev 1998; 50(2): 315-333.
32. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 1925; 42: 753-777.
33. Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981; 25(3): 617-625.
34. Frazier CN, Hu CK. Cutaneous lesions associated with a deficiency in vitamin A in man. Arch Intern Med 1931; 48: 507-514.
35. Molotkov A, Fan X, Deltour L, et al. Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proc Natl Acad Sci U.S.A 2002; 99(8): 5337-5342.
36. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 2003; 143-144: 201-210.
37. Everts HB, King LE Jr, Sundberg JP, et al. Hair cycle-specific immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and Aldh1a3 indicate complex regulation. J Invest Dermatol 2004; 123(2): 258-263.
38. Petkovich PM. Retinoic acid metabolism. J Am Acad Dermatol 2001; 45(5): S136-S142.
39. Perlmann T. Retinoid metabolism: a balancing act. Nat Genet 2002; 31(1): 7-8.
40. Abu-Abed S, MacLean G, Fraulob V, et al. Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev 2002; 110(1-2): 173-177.
41. Ross AC, Zolfaghari R. Regulation of hepatic retinol metabolism: perspectives from studies on vitamin A status. J Nutr 2004; 134(1): 269S-275S.
42. Ghyselinck NB, Bavik C, Sapin V, et al. Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J 1999; 18(18): 4903-4914.
43. E X, Zhang L, Lu J, et al. Increased neonatal mortality in mice lacking cellular retinol-binding protein II. J Biol Chem 2002; 277(39): 36617-36623.
44. Piantedosi R, Ghyselinck N, Blaner WS, et al. Cellular retinol-binding protein type III is needed for retinoid incorporation into milk. J Biol Chem 2005; 280(25): 24286-24292.
45. Batten ML, Imanishi Y, Maeda T, et al. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J Biol Chem 2004; 279(11): 10422-10432.
46. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999; 1440(2-3): 139-162.
47. Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem J 2000; 348(3): 481-495.
48. Gorry P, Lufkin T, Dierich A, et al. The cellular retinoic acid binding protein I is dispensable. Proc Natl Acad Sci U.S.A 1994; 91(19): 9032-9036.
49. Lampron C, Rochette-Egly C, Gorry P, et al. Mice deficient in cellular retinoic acid binding protein II (CRABPII) or in both CRABPI and CRABPII are essentially normal. Development 1995; 121(2): 539-548.
50. Matt N, Dupe V, Garnier JM, et al. Retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. Development 2005; 132(21): 4789-4800.
51. Vermot J, Garnier JM, Dierich A, et al. Conditional (loxP-flanked) allele for the gene encoding the retinoic acid-synthesizing enzyme retinaldehyde dehydrogenase 2 (RALDH2). Genesis 2006; 44(3): 155-158.
52. Dupe V, Matt N, Garnier JM. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc Natl Acad Sci U.S.A 2003; 100(24): 14036-14041.
53. Perissi V, Rosenfeld MG. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 2005; 6(7): 542-554.
54. Laudet V, Gronemeyer H. The Nuclear Receptor Facts Book. London: Academic Press, 2002.
55. Chapellier B, Mark M, Messaddeq N, et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J 2002; 21(13): 3402-3413.
56. Li M, Indra AK, Warot X, et al. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 2000; 407(6804): 633-636.
57. Lufkin T, Lohnes D, Mark M, et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci U.S.A 1993; 90(15): 7225-7229.
58. Lohnes D, Kastner P, Dierich A, et al. Function of retinoic acid receptor gamma in the mouse. Cell 1993; 73(4): 643-658.
59. Kastner P, Mark M, Ghyselinck N, et al. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 1997; 124(2): 313-326.
60. Ghyselinck NB, Dupe V, Dierich A, et al. Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int J Dev Biol 1997; 41(3): 425-447.
61. Mascrez B, Mark M, Dierich A, et al. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 1998; 125(23): 4691-4707.
62. Wendling O, Ghyselinck NB, Chambon P, et al. Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. Development 2001; 128(11): 2031-2038.
63. Kastner P, Grondona JM, Mark M, et al. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994; 78(6): 987-1003.
64. Sucov HM, Dyson E, Gumeringer CL, et al. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994; 8(9): 1007-1018.
65. Li M, Chiba H, Warot X, et al. RXRα ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001; 128(5): 675-688.
66. Calleja C, Messaddeq N, Chapellier B, et al. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev 2006; 20: 1525-1538.
67. Lohnes D, Mark M, Mendelsohn C, et al. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 1994; 120(10): 2723-2748.
68. Chen CF, Lohnes DL. Dominant negative RARs elicit epidermal defects through a non-canonical pathway. J Biol Chem 2005; 280(4): 3012-3021.
69. Mendelsohn C, Lohnes D, Decimo D, et al. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994; 120(10): 2749-2771.
70. Madison KC. Barrier function of the skin: “la raison d’être” of the epidermis. J Invest Dermatol 2003; 121(2): 231-241.
71. Yoshida M, Kijima M, Akita M, et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin. A J Biol Chem 1990; 265(28): 17174-17179.
72. Randolph RK, Siegenthaler G. Vitamin A homeostasis in human epidermis: native retinoid composition and metabolism. In: Nau H, Blaner WS, eds., Retinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. New York: Springer, 1999: 491-520.
73. Saurat JH, Sorg O, Didierjean L. New concepts for delivery of topical retinoid activity to human skin. In: Nau H, Blaner WS, eds., Retinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. New York: Springer, 1999: 521-538.
74. Ohta K, Iijima T, Kawachi E, et al. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety. Bioorg Med Chem Lett 2004; 14(23): 5913-5918.
75. Zhang J, Hu X, Lazar MA. A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol 1999; 19(9): 6448-6457.
76. Westergaard M, Henningsen J, Svendsen ML, et al. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 2001; 116(5): 702-712.
77. Wendling O, Chambon P, Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci U.S.A 1999; 96(2): 547-551.
78. Barak Y, Liao D, He W, et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U.S.A 2002; 99(1): 303-308.
79. Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4(4): 585-595.
80. Rodriguez JC, Gil-Gomez G, Hegardt FG, et al. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 1994; 269(29): 18767-18772.
81. Menon GK, Feingold KR, Mao-Qiang M, et al. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis. J Invest Dermatol 1992; 98(2): 209-219.
82. Germain P, Iyer J, Zechel C, et al. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 2002; 415(6868): 187-192.
83. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004; 3(11): 950-964.
84. Thacher SM, Standeven AM, Athanikar J, et al. Receptor specificity of retinoidinduced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation. J Pharmacol Exp Ther 1997; 282(2): 528-534.
85. Allenby G, Bocquel MT, Saunders M, et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U.S.A 1993; 90(1): 30-34.
86. Dolle P, Ruberte E, Leroy P, et al. Retinoic acid receptors and cellular retinoid binding proteins. I A systematic study of their differential pattern of transcription during mouse organogenesis. Development 1990; 110(4): 1133-1151.
87. Ruberte E, Dolle P, Chambon P, et al. Retinoic acid receptors and cellular retinoid binding proteins. II Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 1991; 111(1): 45-60.
88. Dolle P, Fraulob V, Kastner P, et al. Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev 1994; 45(2): 91-104.
89. Mascrez B, Ghyselinck NB, Watanabe M, et al. Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. EMBO Rep 2004; 5(3): 285-290.
90. Kitareewan S, Burka LT, Tomer KB, et al. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 1996; 7(8): 1153-1166.
91. de Urquiza AM, Liu S, Sjoberg M, et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000; 290(5499): 2140-2144.
92. Goldstein JT, Dobrzyn A, Clagett-Dame M, et al. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch Biochem Biophys 2003; 420(1): 185-193.
93. Mao-Qiang M, Elias PM, Feingold KR. Fatty acids are required for epidermal permeability barrier function. J Clin Invest 1993; 92(2): 791-798.
94. Sundberg JP, Hogan ME, King LE. Normal biology and aging changes of skin and hair. In: Pathobiology of the Aging Mouse. eds. Mohr U, Dungworth DL, Capen CC, Carhon WW, Sundberg JP, Ward JM, Washington: ILSI Press, 1996: 303-323.
95. Oro AE, Scott MP. Splitting hairs: dissecting roles of signaling systems in epidermal development. Cell 1998; 95(5): 575-578.
96. Sundberg JP, King LE. Mouse models for the study of human hair loss. Dermatol Clin 1996; 14(4): 619-632.
97. Panteleyev AA, Paus R, Ahmad W, et al. Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol 1998; 7(5): 249-267.
98. Reichrath J, Schilli M, Kerber A, et al. Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 1994; 131(4): 477-482.
99. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999; 20(2): 156-188.
100. Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U.S.A 1997; 94(18): 9831-9835.
101. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16(4): 391-396.
102. Li YC, Amling M, Pirro AE, et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998; 139(10): 4391-4396.
103. Sakai Y, Demay MB. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology 2000; 141(6): 2043-2049.
104. Chen CH, Sakai Y, Demay MB. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 2001; 142(12): 5386-5389.
105. Sakai Y, Kishimoto J, Demay MB. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest 2001; 107(8): 961-966.
106. Kong J, Li XJ, Gavin D, et al. Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol 2002; 118(4): 631-638.
107. Xie Z, Komuves L, Yu QC, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol 2002; 118(1): 11-16.
108. Fu GK, Lin D, Zhang MY, et al. Cloning of human 25-hydroxyvitamin D-1 alphahydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997; 11(13): 1961-1970.
109. Wang JT, Lin CJ, Burridge SM, et al. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet 1998; 63(6): 1694-1702.
110. Yoshida T, Monkawa T, Tenenhouse HS, et al. Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I1. Kidney Int 1998; 54(5): 1437-1443.
111. Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001; 98(13): 7498-7503.
112. Dardenne O, Prud’homme J, Arabian A, et al. Targeted inactivation of the 25- hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001; 142(7): 3135-3141.
113. Skorija K, Cox M, Sisk JM, et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol 2005; 19(4): 855-862.
114. Yen PM, Liu Y, Sugawara A, et al. Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity. J Biol Chem 1996; 271(18): 10910-10916.
115. Chen JD, Umesono K, Evans RM. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci U.S.A 1996; 93(15): 7567-7571.
116. Tagami T, Lutz WH, Kumar R, et al. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 1998; 253(2): 358-363.
117. Potter GB, Beaudoin GM, DeRenzo CL, et al. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev 2001; 15(20): 2687-2701.
118. Hsieh JC, Sisk JM, Jurutka PW, et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 2003; 278(40): 38665-38674.
119. Li M, Messaddeq N, Teletin M, et al. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U.S.A 2005; 102(41): 14795-14800.
120. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004; 113(5): 651-657.
121. Leung DY, Jain N, Leo HL. New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003; 15(6): 634-638.
122. Esche C, de Benedetto A, Beck LA. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 2004; 4(4): 276-284.
123. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361(9352): 151-160.
124. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112(6 Suppl): S118-S127.
125. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5(7): 752-760.
126. Soumelis V, Liu YJ. Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation. Springer Semin Immunopathol 2004; 25(3-4): 325-333.
127. Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19(8): 359-361.
128. Jelinek DF. Regulation of B lymphocyte differentiation. Ann Allergy Asthma Immunol 2000; 84(4): 375-385.
129. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167(1): 219-224.
130. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3(7): 673-680.
131. Li M, Hener P, Zhang Z, et al. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U.S.A 2006; 103: 11736-11741.
132. Billoni N, Buan B, Gautier B, et al. Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 2000; 142(4): 645-652.
133. Peters JM, Lee SS, Li W, et al. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta). Mol Cell Biol 2000; 20(14): 5119-5128.
134. Michalik L, Desvergne B, Tan NS, et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta mutant mice. J Cell Biol 2001; 154(4): 799-814.
135. Goyette P, Feng-Chen C, Wang W, et al. Characterization of retinoic acid receptordeficient keratinocytes. J Biol Chem 2000; 275(22): 16497-16505.
136. Chen S, Ostrowski J, Whiting G, et al. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 1995; 104(5): 779-783.
137. Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003; 284(1): 2-13.
138. Jorissen RN, Walker F, Pouliot N, et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003; 284(1): 31-53.
139. Stoll SW, Elder JT. Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 1998; 7(6): 391-397.
140. Xiao JH, Feng X, Di W, et al. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 1999; 18(6): 1539-1548.
141. Downing MT, Brigstock DR, Luquette MH, et al. Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers. Histochem J 1997; 29(10): 735-744.
142. Rittie L, Varani J, Kang S, et al. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 2006; 126(4): 732-739.
143. Strachan L, Murison JG, Prestidge RL, et al. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 2001; 276(21): 18265-18271.
144. Kimura R, Iwamoto R, Mekada E. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia. Cell Struct Funct 2005; 30(2): 35-42.
145. Shirakata Y, Kimura R, Nanba D, et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 2005; 118(11): 2363-2370.
146. Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986; 15(4): 817-821.
147. Taneja R, Rochette-Egly C, Plassat JL, et al. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 1997; 16(21): 6452-6465.
148. Rochette-Egly C, Adam S, Rossignol M, et al. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 1997; 90(1): 97-107.
149. Chapellier B, Mark M, Garnier JM, et al. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor gamma (RARgamma) gene. Genesis 2002; 32(2): 95-98.
150. Chapellier B, Mark M, Garnier JM, et al. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor alpha (RARalpha) gene. Genesis 2002; 32(2): 87-99.